TACRINE
Introduction to Tacrine Tacrine, marketed historically under the trade name Cognex, represents a significant, though now less frequently utilized, pharmacological agent in the treatment of cognitive decline associated with dementia, most notably Alzheimer’s disease (AD). This compound was groundbreaking as it was the first centrally acting acetylcholinesterase inhibitor approved by the U.S. Food and Drug […]